Tumours not expressing the oestrogen receptor (ER) or progesterone receptor (PR) and have no human epidermal growth factor receptor 2 (HER2; also referred to by its gene name ERBB2) amplification are classified as triple-negative breast cancer (TNBC) [105]. Here, ERBB2 is linked to triple-negative breast carcinoma.